Hepatitis C Treatment Snapshots: ledipasvir and sofosbuvir co-formulation

Hepatitis C Treatment Snapshots: ledipasvir and sofosbuvir co-formulation

For a simplified snapshot from TREAT Asia/amfAR on ledipasvir and sofosbuvir co-formulation for the treatment of hepatitis C, please click here.

/ News

Share the Post

Related Posts

Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs
Updated Generic Sofosbuvir Availability and Price in India 15 June 2015
Updated Patent Situation on Key Products for Hepatitis C Treatment in Asia – August 2015
Stage set for access to Hepatitis C treatment in Malaysia
Pricing and availability of generic Indian daclatasvir as on 7 March 2016
Community group taking actions to enable greater access for generic HCV treatment
20 YEARS AFTER THE TRIPS AGREEMENT, U.S. GOVERNMENT SCORES MASSIVE VICTORY FOR BIG PHARMA IN TPP DEAL
APN+ joins MTAAG in congratulating Malaysia on sofosbuvir compulsory license